News Center Laboratories, Inc.

Equities

4123

TW0004123005

End-of-day quote Taipei Exchange Other stock markets 06:00:00 2024-04-21 pm EDT			5-day change	1st Jan Change
42.5 ^TWD	+1.19%		-1.62%	-4.06%

Mar. 19	Center Laboratories, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Mar. 13	Mycenax Biotech Inc. announced that it expects to receive funding from Center Laboratories, Inc., JCR Pharmaceuticals Co., Ltd., Taiwan BioVenture Company, Jason Technologies Ltd	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Center Laboratories, Inc. cancelled the transaction announced on June 20, 2023	Apr. 21	CI
Center Laboratories, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 19	CI
Mycenax Biotech Inc. announced that it expects to receive funding from Center Laboratories, Inc., JCR Pharmaceuticals Co., Ltd., Taiwan BioVenture Company, Jason Technologies Ltd	Mar. 12	CI
Center Laboratories, Inc. Announces Wang, Su-Chi Holds Concurrent Position as Chief Investment Officer and Chief Operating Officer	Feb. 06	CI
Center Laboratories, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 10	CI
Center Laboratories, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-11	CI
Center Laboratories, Inc. Announces Cash Dividend Distribution for the Year 2022, Payable on October 13, 2023	23-08-11	CI
Center Laboratories, Inc. announced a financing transaction	23-06-19	CI
Center Laboratories, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-15	CI
Center Laboratories, Inc. Proposes Cash Dividend for the Period from January 1, 2022 to December 31, 2022	23-04-20	CI
Center Laboratories, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-28	CI
Center Laboratories, Inc. Announces Executive Appointments	22-12-08	CI
Center Laboratories, Inc. Announces Management Changes	22-11-30	CI
Center Laboratories, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-09	CI
Bao Pharma announced that it has received $100 million in funding from Shenzhen Oriental Fortune Capital Co., Ltd., Finnova Capital, Haitong Innovation Private Fund Management Co., Ltd., Shanghai Sun Rock Capital Management Co., Ltd., Center Laboratories, Inc.	22-08-24	CI
Center Laboratories, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-11	CI
Center Laboratories : To announce the ex-rights and dividend record date and the closure period for the conversion of CB4 and CB5	22-08-11	PU
Center Laboratories, Inc. Announces Cash Dividend Distribution for the Year 2021	22-08-11	CI
Center Laboratories : Amendment on the Company's 2021 Annual Report	22-08-10	PU
Center Laboratories : Announcement on the change of internal audit officer	22-07-27	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Center Laboratories, Inc.

Equities

4123

TW0004123005

Summary

Filters